Ignite Creation Date:
2024-05-06 @ 8:20 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02717962
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-22
First Post:
2016-03-16
Brief Title:
Study of VAL-083 in Patients With MGMT Unmethylated Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
Sponsor:
Kintara Therapeutics Inc
Organization:
Kintara Therapeutics Inc
Organization Data
Organization:
Kintara Therapeutics Inc
Class:
INDUSTRY
Study ID:
DLM-16-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kintara Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None